Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression. | Cancers (Basel) | 2022 | 36612181 | PubTator, text mining | PubMed |
| Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen. | Front Oncol | 2022 | 36601474 | PubTator, text mining | PubMed |
| Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition). | Liver Cancer | 2022 | 36589726 | PubTator, text mining | PubMed |
| Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features. | Diagn Pathol | 2022 | 36585729 | PubTator, text mining | PubMed |
| Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients. | Cancer Cell Int | 2022 | 36585652 | PubTator, text mining | PubMed |
| Increased HRD score in cisplatin resistant penile cancer cells. | BMC Cancer | 2022 | 36564761 | PubTator, text mining | PubMed |
| Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting. | J Clin Med | 2022 | 36556033 | PubTator, text mining | PubMed |
| Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis. | Int J Environ Res Public Health | 2022 | 36554603 | PubTator, text mining | PubMed |
| Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer. | Mol Biomed | 2022 | 36508072 | PubTator, text mining | PubMed |
| Case Report: Small intestinal metastatic breast cancer: A case report and literature review. | Front Oncol | 2022 | 36505863 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| Systemic therapies in hepatocellular carcinoma: Existing and emerging biomarkers for treatment response. | Front Oncol | 2022 | 36483039 | PubTator, text mining | PubMed |
| Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report. | J Ovarian Res | 2022 | 36463302 | PubTator, text mining | PubMed |
| Targeting the FGF/FGFR axis and its co-alteration allies. | ESMO Open | 2022 | 36455506 | PubTator, text mining | PubMed |
| Studies on the Regioselective Rearrangement of Azanorbornanic Aminyl Radicals into 2,8-Diazabicyclo[3.2.1]oct-2-ene Systems. | J Org Chem | 2022 | 36455216 | PubTator, text mining | PubMed |
| Pseudogenes in Juvenile Nasopharyngeal Angiofibroma: First Pilot Observation. | Indian J Otolaryngol Head Neck Surg | 2022 | 36452697 | PubTator, text mining | PubMed |
| Application of Peptides in Construction of Nonviral Vectors for Gene Delivery. | Nanomaterials (Basel) | 2022 | 36432361 | PubTator, text mining | PubMed |
| Ionizing Radiation and Estrogen Affecting Growth Factor Genes in an Experimental Breast Cancer Model. | Int J Mol Sci | 2022 | 36430763 | PubTator, text mining | PubMed |
| Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications. | Int J Mol Sci | 2022 | 36430344 | PubTator, text mining | PubMed |
| Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report. | Cancer Manag Res | 2022 | 36411743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=16